Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Adv Wound Care (New Rochelle) ; 11(12): 666-686, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-34376065

RESUMO

Diabetic foot ulcerations have devastating complications, including amputations, poor quality of life, and life-threatening infections. Diabetic wounds can be protracted, take significant time to heal, and can recur after healing. They are costly consuming health care resources. These consequences have serious public health and clinical implications. Debridement is often used as a standard of care. Debridement consists of both nonmechanical (autolytic, enzymatic) and mechanical methods (sharp/surgical, wet to dry debridement, aqueous high-pressure lavage, ultrasound, and biosurgery/maggot debridement therapy). It is used to remove nonviable tissue, to facilitate wound healing, and help prevent these serious outcomes. What are the various forms and rationale behind debridement? This article comprehensively reviews cutting-edge methods and the science behind debridement and diabetic foot ulcers.


Assuntos
Diabetes Mellitus , Pé Diabético , Úlcera do Pé , Desbridamento/efeitos adversos , Pé Diabético/cirurgia , Úlcera do Pé/complicações , Humanos , Qualidade de Vida , Cicatrização
2.
Undersea Hyperb Med ; 48(3): 209-219, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34390625

RESUMO

Eustachian tube dysfunction (ETD) and middle ear barotrauma (MEB) are common reported complications during hyperbaric oxygen treatment. Our Phase I study data was the first to demonstrate a statistically significant decrease in the occurrence of symptomatic ETD and MEB. The Phase I Trial suggested the total time interval and rate (slope) of compression (ROC) may be a determining factor in ETD and MEB. This Phase II study investigates an optimal rate of compression to reduce ETD and MEB when considering each multiplace treatment (with multiple patients) as the unit of observation as a group, rather than for each individual patient. Data were collected prospectively on 1,244 group patient-treatment exposures, collectively including 5,072 individual patient-treatment/exposures. We randomly assigned patient-treatment group exposures to four different time interval and rate (slope) of compression. These compression rates and slopes were identical to those used in the Phase I trial. All patients experiencing symptoms of MEB requiring compression stops were evaluated post treatment for the presence of ETD and MEB using the O'Neill Grading System (OGS) for ETD. Data were analyzed using the IBM-SPSS statistical software program. A statistically significant decrease in the number of compression holds was observed in the 15-minute compression schedule, correlating to the results observed in the Phase I trial. The 15-minute linear compression profile continues to demonstrate the decreased need for patient symptomatic compression stops (as in the Phase I trial) using a USN TT9 during elective hyperbaric oxygen treatments in a Class A multiplace hyperbaric chamber. Trial Registration: ClinicalTrials.gov Identifier: NCT04776967.


Assuntos
Barotrauma/epidemiologia , Otopatias/epidemiologia , Orelha Média/lesões , Tuba Auditiva/lesões , Oxigenoterapia Hiperbárica/efeitos adversos , Barotrauma/etiologia , Barotrauma/prevenção & controle , Otopatias/etiologia , Otopatias/prevenção & controle , Orelha Média/fisiologia , Humanos , Oxigenoterapia Hiperbárica/métodos , Oxigenoterapia Hiperbárica/estatística & dados numéricos , Incidência , Pressão/efeitos adversos , Estudos Prospectivos , Análise de Regressão , Fatores de Tempo , Suspensão de Tratamento/estatística & dados numéricos
3.
Respir Med ; 179: 106312, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33636568

RESUMO

INTRODUCTION: Efforts to meet increased oxygen demands in COVID-19 patients are a priority in averting mechanical ventilation (MV), associated with high mortality approaching 76.4-97.2%. Novel methods of oxygen delivery could mitigate that risk. Oxygen hoods/helmets may improve: O2-saturation (SaO2), reduce in-hospital mechanical ventilation and mortality rates, and reduce length of hospitalization in hypoxic Covid-19 patients failing on conventional high-flow oxygen delivery systems. METHODS: DesignProspective Controlled Cohort Study. SettingSingle Center. ParticipantsAll patients admitted with a diagnosis of COVID-19 were reviewed and 136/347 patients met inclusion criteria. Study period3/6/2020 to 5/1/2020. 136 participants completed the study with known status for all outcome measures. Intervention or exposureOxygen hoods/helmets as compared to conventional high-flow oxygen delivery systems. MAIN OUTCOME(S) AND MEASURE(S): 1) Pre and post change in oxygen saturation (SaO2). 2) In-hospital Mechanical Ventilation (MV). 3) In-hospital Mortality. 4) Length of hospitalization. RESULTS: 136 patients including 58-intervention and 78-control patients were studied. Age, gender, and other demographics/prognostic indicators were comparable between cohorts. Oxygen hoods averted imminent or immediate intubation/MV in all 58 COVID-19 patients failing on conventional high-flow oxygen delivery systems with a mean improvement in SaO2 of 8.8%, p < 0.001. MV rates were observed to be higher in the control 37/78 (47.4%) as compared to the intervention cohort 23/58 (39.7%), a difference of 7.7%, a 27% risk reduction, not statistically significant, OR 95%CI 0.73 (0.37-1.5). Mortality rates were observed higher in the control 54/78 (69.2%) as compared to the intervention cohort 36/58 (62.1%), a difference of 7.1%, a 27% risk reduction, not statistically significant OR 95%CI 0.73 (0.36-1.5). CONCLUSION: Oxygen hoods demonstrate improvement in SaO2 for patients failing on conventional high-flow oxygen-delivery systems and prevented imminent mechanical ventilation. In-hospital mechanical ventilation and mortality rates were reduced with the use of oxygen hoods but not found to be statistically significant. The oxygen hood is a safe, effective oxygen-delivery system which may reduce intubation/MV and mortality rates. Their use should be considered in treating hypoxic COVID-19 patients. Further research is warranted. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04407260.


Assuntos
COVID-19/complicações , Hipóxia/terapia , Consumo de Oxigênio/fisiologia , Oxigenoterapia/instrumentação , Respiração Artificial/instrumentação , Adulto , Idoso , Idoso de 80 Anos ou mais , COVID-19/epidemiologia , Falha de Equipamento , Feminino , Humanos , Hipóxia/etiologia , Hipóxia/mortalidade , Masculino , Pessoa de Meia-Idade , Pandemias , Prognóstico , Estudos Prospectivos , Taxa de Sobrevida/tendências , Falha de Tratamento , Estados Unidos/epidemiologia
4.
Undersea Hyperb Med ; 46(4): 447-459, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31509901

RESUMO

INTRODUCTION: The mining and tunneling industries are historically associated with hazardous exposures that result in significant occupational health concerns. Occupational respiratory exposures causing pneumoconiosis and silicosis are of great concern, silicosis being non-curable. This work demonstrates that compressed-air workers (CAWs) performing tunnel hyperbaric interventions (HIs) may be at risk for hazards related to bentonite exposure, increasing the likelihood of developing harmful illnesses including cancer. Bentonite dust inhalation may result in respiratory levels of silica exceeding acceptable industrial hygiene standards. METHODS: A qualitative observational exposure assessment was conducted on CAWs while they were performing their HI duties. This was followed by quantitative data collection using personal and area air sample techniques. The results were analyzed and interpreted using standard industrial hygiene principles and guidelines from NIOSH and OSHA. RESULTS: Our work suggests bentonite dust exposure may be an emerging particulate matter concern among CAWs in the tunneling industry. Aerosolized bentonite particles may have potential deleterious effects that include pneumoconiosis and silicosis. Silicosis can result in the development of pulmonary carcinoma. CONCLUSIONS: The modern tunneling industry and required hyperbaric interventional tasks represent a potential public health and occupational concern for CAWs. This paper introduces the modern tunneling industry and the duties of CAWs, the hazardous environment in which they perform their duties, and describes the risks and potential harmful health effects associated with these hazardous exposures.


Assuntos
Bentonita/toxicidade , Ar Comprimido , Materiais de Construção/toxicidade , Poeira , Arquitetura de Instituições de Saúde , Exposição Ocupacional/efeitos adversos , Poluentes Ocupacionais do Ar/química , Poluentes Ocupacionais do Ar/toxicidade , Bentonita/química , Indústria da Construção , Materiais de Construção/análise , Segurança de Equipamentos , Filtração/instrumentação , Humanos , Pressão , Pesquisa Qualitativa , Dispositivos de Proteção Respiratória , Estados Unidos , United States Occupational Safety and Health Administration/normas
5.
Undersea Hyperb Med ; 46(1): 55-61, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31154685

RESUMO

Introduction: Eustachian tube dysfunction (ETD) and middle ear barotrauma (MEB) are the most common adverse effects of hyperbaric oxygen (HBO2) treatments. Patients practice equalization maneuvers to prevent ETD and MEB prior to hyperbaric exposure. Some patients are still unable to equalize middle ear pressure. This ETD results in undesirable consequences, including barotrauma, treatment with medications or surgical myringotomy with tube placement and interruption of HBO2. When additional medications and myringotomy are employed, they are associated with additional complications. Methods: A device known as the Ear Popper® has been reported to reduce complications from serous otitis media and reduce the need for surgical interventions (myringotomy). Patients unable to equalize middle ear pressure during initial compression in the hyperbaric chamber were allowed to use the device for rescue. All hyperbaric treatments were compressed using a United States Navy TT9, or a 45-fsw hyperbaric treatment schedule. Patients with persistent ETD and the inability to equalize middle ear pressure were given the Ear Popper upon consideration of terminating their treatment. Results: The Ear Popper allowed all patients to successfully equalize middle ear pressure and complete their treatments. Conclusion: This study substantiates the use of this device to assist in allowing pressurization of the middle ear space in patients otherwise unable to achieve equalization of middle ear pressure during HBO2 treatment in a multiplace chamber.


Assuntos
Barotrauma/prevenção & controle , Otopatias/prevenção & controle , Tuba Auditiva , Oxigenoterapia Hiperbárica/efeitos adversos , Estudo de Prova de Conceito , Terapia de Salvação/instrumentação , Adulto , Idoso , Idoso de 80 Anos ou mais , Pressão Atmosférica , Deglutição , Desenho de Equipamento , Tuba Auditiva/fisiologia , Feminino , História do Século XIX , Humanos , Masculino , Pessoa de Meia-Idade , Otolaringologia/história , Terapia de Salvação/métodos
6.
Undersea Hyperb Med ; 42(3): 265-71, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26152108

RESUMO

Eustachian tube dysfunction (ETD) and middle ear barotrauma (MEB) are the two most common complications of clinical hyperbaric oxygen (HBO2) treatment. The current grading system, the Teed's Classification, was first described in 1944 with modifications to this system over the years, but none are specific for the evaluation and treatment of patients undergoing clinical HBO2 therapy. Currently, the standard of care is a baseline otoscopic examination performed prior to starting HBO2 therapy. Repeat otoscopy is required for patients having ETD, pain or other symptoms during the compression and/or decompression phase of the treatment. Results from these examinations are used to determine the proper course of treatment for the ETD or MEB. The Teed's classification was not intended to correlate with the consistency of diagnosis, the clinical approach to relieving symptoms or the treatment of the inflicted trauma. It is not a practical tool for the modern hyperbaric team. We describe a newer grading system, the O'Neill Grading System (OGS), which allows simple, practical and consistent classification of ETD and MEB by all members of the clinical hyperbaric medicine team. Based on the O'Neill Grade assigned, evidence supported suggestions for appropriate actions and medical interventions are offered.


Assuntos
Barotrauma/classificação , Orelha Média/lesões , Oxigenoterapia Hiperbárica/efeitos adversos , Otoscopia/métodos , Membrana Timpânica/lesões , Barotrauma/diagnóstico , Barotrauma/etiologia , Barotrauma/terapia , Tuba Auditiva/lesões , Humanos , Ilustração Médica , Otoscópios , Fotografação , Ruptura/classificação , Perfuração da Membrana Timpânica/classificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...